Popisný Odchozí to je vše double expresor vs double hit overall survival Připraveno Prezident Alergie
Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome | Haematologica
Survival in double hit and double expressor DLBCL
Diffuse Large B Cell Lymphoma:
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation
How should we treat double hit and double expressor lymphomas?
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation | Journal of Clinical Oncology
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica
Double hit and double expressors in lymphoma: Definition and treatment - Riedell - 2018 - Cancer - Wiley Online Library
Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell Transplantation - Biology of Blood and Marrow Transplantation
Overall survival comparison between patients with atypical double-hit... | Download Scientific Diagram
Patterns of Failure in Patients With Double Hit or Double Expressor Lymphomas: Implications for Radiation Therapy - ScienceDirect
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation | Journal of Clinical Oncology
Double hit and double expressors in lymphoma: Definition and treatment - Riedell - 2018 - Cancer - Wiley Online Library
Applied Sciences | Free Full-Text | High-Grade B-Cell Lymphoma Not Otherwise Specified (HGBL, NOS) in the Maxillary Sinus Mimicking Periapical Inflammation: Case Report and Review of the Literature
Diffuse Large B Cell Lymphoma:
Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single
Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | SpringerLink
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia
Diagnostics | Free Full-Text | Molecular Diagnostic Review of Diffuse Large B-Cell Lymphoma and Its Tumor Microenvironment
Exploiting the Molecular Heterogeneity of Aggressive B-Cell Lymphomas to Develop Effective New Therapies
How should we treat double hit and double expressor lymphomas?
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica